1303606-44-1

Basic information

• Product Name: (2′R,3S,4′R,5′R)-6-chloro-4′-(3-chlorophenyl)-N-((1s,3S)-3-hydroxy-3-methylcyclobutyl)-2′-neopentyl-2-oxospiro[indoline-3,3′-pyrrolidine]-5′-carboxamide trifluoroacetic acid
• Synonyms: (2′R,3S,4′R,5′R)-6-chloro-4′-(3-chlorophenyl)-N-((1s,3S)-3-hydroxy-3-methylcyclobutyl)-2′-neopentyl-2-oxospiro[indoline-3,3′-pyrrolidine]-5′-carboxamide trifluoroacetic acid
• CAS NO: 1303606-44-1
• Molecular Weight: 662.509
• Mol File: 1303606-44-1.mol

Chemical Properties

• CAS DataBase Reference: (2′R,3S,4′R,5′R)-6-chloro-4′-(3-chlorophenyl)-N-((1s,3S)-3-hydroxy-3-methylcyclobutyl)-2′-neopentyl-2-oxospiro[indoline-3,3′-pyrrolidine]-5′-carboxamide trifluoroacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2′R,3S,4′R,5′R)-6-chloro-4′-(3-chlorophenyl)-N-((1s,3S)-3-hydroxy-3-methylcyclobutyl)-2′-neopentyl-2-oxospiro[indoline-3,3′-pyrrolidine]-5′-carboxamide trifluoroacetic acid(1303606-44-1)
• EPA Substance Registry System: (2′R,3S,4′R,5′R)-6-chloro-4′-(3-chlorophenyl)-N-((1s,3S)-3-hydroxy-3-methylcyclobutyl)-2′-neopentyl-2-oxospiro[indoline-3,3′-pyrrolidine]-5′-carboxamide trifluoroacetic acid(1303606-44-1)

Safety Data

• Hazardous Substances Data: 1303606-44-1(Hazardous Substances Data)

Upstream product

• 85070-48-0 2-fluoro-3-chlorobenzaldehyde 
• 1303609-27-9 C₄₈H₅₈Cl₂FN₃O₄Si 
• 897365-81-0 (3S,3'S,4'R,6'R,8'S,8a'R)-6-chloro-8'-(3-chloro-2-fluorophenyl)-6'-neopentyl-3',4'-diphenyl-3',4',8',8a'-tetrahydrospiro[indoline-3,7'-pyrrolo[2,1-c][1,4]oxazine]-1',2(6'H)-dione 
• 1303609-25-7 cis-3-((tert-butyldimethylsilyl)oxy)-3-methylcyclobutan-1-amine 
• 1303609-23-5 benzyl 3-(tert-butyldimethylsilyloxy)-3-methylcyclobutylcarbamate 
• 1303609-22-4 3-[tert-butyl(dimethyl)silyl]oxy-3-methylcyclobutanecarboxylic acid 
• 897365-76-3 (3E/Z)-6-chloro-3-(3-chloro-2-fluorobenzylidene)-1,3-dihydro-2H-indol-2-one 
• 74444-81-8 5-chloro-1,3-dihydro-2H-inden-2-one 

Relevant articles and documents

SPIRO-OXINDOLE MDM2 ANTAGONISTS

Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as